Newlink genetics stock
Web8 nov. 2024 · NewLink Genetics is currently traded at ~$2.15 per share.The cash value of the stock given the projected balance sheet on December 31, 2024, is ~$2.88. With upcoming catalysts by mid-2024, the ... WebNewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer …
Newlink genetics stock
Did you know?
Web13 mrt. 2024 · Best-in-Class Portfolio Monitoring. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Web10 jul. 2024 · AMES, Iowa, July 10, 2024 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it has received a Notice of Allowance for U.S. patent application number 15/171,031 ...
Web9 jun. 2024 · June 8, 2024 By Mark Terry, BioSpace.com Breaking News Staff Ames, Iowa – NewLink Genetics announced that Genentech was returning the rights to its IDO inhibitor GDC-0919 (navoximod). However, the overall research collaboration the two companies have to identify the next generation IDO/TDO (tryptophan 2,3-dioxygenase) inhibitors will … WebAccording to the current price, NewLink Genetics is 34.51% away from the 52-week high. What are analysts forecasts for NewLink Genetics stock? The 6 analysts offering price forecasts for...
WebWhich shareholders are buying/selling shares of NewLink Genetics (NASDAQ:NLNK) stock? View NLNK institutional ownership (13F) transactions at MarketBeat. Skip to main content. Get MarketBeat Daily Premium for Just $199 $89! Claim Your Discount. × . S&P 500 . DOW . QQQ 301.16.
Web4 okt. 2024 · Shares of NewLink Genetics Corp. ( NLNK), a clinical stage biotech with an oncology focus, are rising in response to a secondary offering that ended up priced much …
WebStock analysis for Lumos Pharma Inc (NLNK) including stock price, stock chart, company news, key statistics, fundamentals and company profile. mfc themechangedWeb3 mei 2024 · NewLink Genetics Corporation (NLNK) (Delayed Data from NSDQ) $1.79 USD +0.06 (3.47%) Updated May 3, 2024 04:00 PM ET After-Market: $1.78 (%) 5:22 PM … mfc themeWebInvestors in NewLink Genetics Corporation (NASDAQ:NLNK) need to pay close attention to the stock based on moves in the options market lately. That is because the Jan … how to calculate auc infinityWeb11 sep. 2024 · Summary. Positive phase 2 data brings life back to NewLink Genetics stock. Previous failures in metastatic breast cancer and pancreatic cancer vaccine brought down investor confidence. mfc theoryWebNewlink Genetics stock rating What analysts recommend for NLNK stock, on a scale from 1 (buy) to 5 (sell). Buy Sell 1 Newlink Genetics price target What analysts think NLNK will be worth Low $0 High $23.71 Current $0 Target $23.71 Events List of events that could affect NLNK stock. 28 Feb Earnings data Q4 2024 12AM GMT-3 07 May how to calculate a two year averageWeb3 mei 2024 · On May 5, NewLink Genetics will release earnings for Q1. Wall Street analysts expect NewLink Genetics will be reporting losses per share of $0.874. Go here to track NewLink Genetics stock price in ... mfc this 静的関数Web30 sep. 2024 · Lumos Pharma, Inc. signed a letter of intent to acquire NewLink Genetics Corporation in a reverse merger transaction on July 26, 2024. Lumos Pharma, Inc ... shares of Lumos Pharma capital stock will be converted into the right to receive a number of newly issued shares of NewLink common stock at exchange ratios applicable to each ... mfc this